C-Suite COVID-19 Challenges - Ep 3 by SurfingMASH published on 2020-07-30T15:55:19Z Critical considerations for companies developing NASH drugs Peter Traber focuses on ways COVID-19 can affect drug development and broader corporate strategies while our panelists weigh in on implications for clinical researchers, investors and forecasters in our third episode: C-SUITE COVID-19 CHALLENGES. --- Full Transcription: https://bit.ly/CSuiteCOVID19Challenges Apple Podcasts: https://bit.ly/NASH-Podcast-Apple Spotify: https://bit.ly/NASH-Podcast-Spotify Stitcher: https://bit.ly/NASH-Podcast-Stitcher Buzzsprout: https://bit.ly/NASH-Podcast-Buzzsprout YouTube: https://bit.ly/NASH-Podcast-YT Genre